Preclinical exploration of the potential antiinflammatory properties of the peptide leukotriene antagonist ICI 204,219 (Accolate).
Krell
R D
RD
ZENECA Pharmaceuticals Group, Department of Pharmacology, Wilmington, Delaware 19897.
Dehaas
C J
CJ
Lengel
D J
DJ
Kusner
E J
EJ
Williams
J C
JC
Buckner
C K
CK
D000818:Animals; D002199:Capillary Permeability; D002465:Cell Movement; D004804:Eosinophils / Q000502:physiology; D006168:Guinea Pigs; D007211:Indoles; D007958:Leukocyte Count; D017998:Leukotriene D4 / Q000037:antagonists & inhibitors*; D008168:Lung / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D048448:Phenylcarbamates; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000493:pharmacokinetics / Q000494:pharmacology*
D007211:Indoles; D048448:Phenylcarbamates; D013449:Sulfonamides; D014105:Tosyl Compounds; D017998:Leukotriene D4; C062735:zafirlukast